Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apyx Medical (APYX) FCF Margin (2016 - 2025)

Apyx Medical (APYX) has disclosed FCF Margin for 15 consecutive years, with 14.64% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, FCF Margin rose 774.0% year-over-year to 14.64%, compared with a TTM value of 17.25% through Dec 2025, up 2177.0%, and an annual FY2025 reading of 17.25%, up 2177.0% over the prior year.
  • FCF Margin was 14.64% for Q4 2025 at Apyx Medical, up from 31.49% in the prior quarter.
  • Across five years, FCF Margin topped out at 29.41% in Q3 2023 and bottomed at 62.24% in Q1 2024.
  • Average FCF Margin over 5 years is 28.51%, with a median of 31.7% recorded in 2021.
  • The sharpest move saw FCF Margin skyrocketed 12405bps in 2021, then tumbled -6939bps in 2024.
  • Year by year, FCF Margin stood at 0.7% in 2021, then tumbled by -5182bps to 37.05% in 2022, then skyrocketed by 58bps to 15.72% in 2023, then tumbled by -42bps to 22.37% in 2024, then surged by 35bps to 14.64% in 2025.
  • Business Quant data shows FCF Margin for APYX at 14.64% in Q4 2025, 31.49% in Q3 2025, and 13.17% in Q2 2025.